Simultaneous Analysis of API and Related Impurities Using SPD-M40 X4 Photodiode Array Detector

Significance of the topic

Pharmaceutical impurity analysis requires simultaneous, accurate quantification of the active pharmaceutical ingredient (API) and trace-level related impurities. A common analytical challenge is that concentration levels needed to detect low-abundance impurities often saturate detector response for the API, forcing multiple dilutions and repeated injections. A detector and UHPLC configuration that preserve linearity across a wide dynamic range reduces sample handling, shortens workflows, and improves result reliability.

Aims and overview of the study

This application note demonstrates simultaneous analysis and quantification of an API and its related impurity in a single injection using Shimadzu’s Nexera X4 UHPLC platform equipped with the SPD-M40 X4 photodiode array (PDA) detector. Using salicylic acid as a model small-molecule API, the study evaluated high-concentration calibration linearity (up to ~3 AU peak height) and the repeatability of retention time and peak area for a low-level impurity present in a high-concentration API matrix.

Used instrumentation

• UHPLC system: Nexera X4 (Shimadzu)
• Detector: SPD-M40 X4 photodiode array detector, standard cell, monitoring at 299 nm
• Column: Shim-pack Scepter C18-120, 50 mm × 2.1 mm I.D., 1.9 µm
• Mobile phase: Pump A = 0.1% formic acid in water; Pump B = acetonitrile
• Gradient: 5% B at 0 min → 95% B at 1.4 min → 5% B from 1.4 to 2.6 min
• Column temperature: 40 °C
• Flow rate: 0.5 mL/min with micro mixer
• Sample loop: 15 µL; injection volume: 1 µL

Methodology

Salicylic acid solutions spanning peak heights from approximately 1.0 to 3.0 AU were prepared to assess detector linearity in a high-concentration range. A calibration curve was constructed from five calibration points corresponding to peak heights of 1, 1.5, 2, 2.5 and 3 AU (nominal concentrations reported in the application note). Linearity (r²) and back-calculated percent error were evaluated. Reproducibility was assessed by performing six replicate injections of a high-concentration salicylic acid sample that contained a low-level impurity (~0.05% area) and measuring %RSD for retention time and peak area for both API and impurity.

Main results and discussion

• Linearity: The calibration curve for salicylic acid in the high-concentration range showed excellent linearity with r² > 0.9999 across peak heights up to ~3 AU.
• Accuracy (back-calculated error): Percent errors for back-calculated concentrations at calibration points in the 1–3 AU range were small (approximately 0.26–0.37%), indicating accurate quantification even at high absorbance.
• Dynamic range: SPD-M40 X4 maintained linear response up to ~3 AU, allowing a salicylic acid peak of ~2.75 AU to be quantified without dilution.
• Reproducibility: Six replicate injections produced excellent repeatability. Retention time %RSDs were 0.016% for salicylic acid and 0.032% for the impurity; peak area %RSDs were 0.38% for salicylic acid and 0.45% for the impurity.
• Impurity detection: A low-level impurity at ~0.052% area was clearly detected and quantified with high precision within the same injection as the high-concentration API peak.

These results demonstrate that a PDA detector with an extended linear range reduces or removes the need for alternate sample dilutions when quantifying both major components and trace impurities in a single analysis, improving throughput and lowering the risk of dilution-related errors.

Benefits and practical applications

• Single-injection quantification of API and trace impurities reduces sample preparation time and labor.
• Expanded detector linearity minimizes reanalysis and potential dilution errors, beneficial for stability studies, batch release testing, impurity profiling, and method development.
• High repeatability supports robust routine QA/QC operations and regulatory submissions requiring precise impurity quantification.
• Compatibility with common reversed-phase UHPLC packing and solvent systems facilitates adoption in existing workflows.

Future trends and potential applications

• Extending linear dynamic range further (beyond 3 AU) and optimizing detector electronics and optics could enable even broader single-injection analyses for larger concentration spans.
• Combining wide-range PDA detection with mass spectrometry (LC–MS) would add orthogonal specificity for impurity identification while retaining the benefit of single-injection quantification.
• Automation and workflow integration — including autosamplers, online dilution or trapping strategies, and informatics for automated calibration checks — can further increase laboratory throughput.
• Advanced data processing (deconvolution, chemometrics, AI-assisted peak purity assessment) can improve impurity identification and quantification in complex matrices.
• Regulatory focus on robust, efficient impurity control will continue to drive demand for instruments that deliver wide dynamic ranges with high repeatability.

Conclusion

The Nexera X4 platform coupled with the SPD-M40 X4 PDA detector demonstrates reliable linearity up to ~3 AU and high reproducibility, enabling simultaneous quantification of a high-concentration API and trace impurity in a single injection. This capability streamlines impurity analysis workflows, reduces sample handling and potential dilution errors, and supports routine pharmaceutical QA/QC and method development needs.

References

• Shimadzu Corporation. Simultaneous Analysis of API and Related Impurities Using SPD-M40 X4 Photodiode Array Detector. Application News, First Edition, Feb 2026. Author: Shinichi Fujisaki.